# Yuandong Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yuandong-biotechnology

- Industry: Materials
- Headquarters: Guangzhou, China
- Latest round: Series A (Dec 10, 2025)
- Investors on record: 3

## About

Based in Guangzhou, China, and founded in 2024, Guangzhou Yuandong Biotechnology Co., Ltd., trading as Yuandong Biotechnology, focuses on the new energy industry, producing nanocellulose and its derivatives for performance enhancement in lithium-ion battery anode binders, lithium-ion battery separators, and all-solid-state battery materials. In December 2025, Yuandong Biotechnology raised a series A funding from new investors Dalton Venture, Winzac Capital Management and other investors.
The company primarily engages in the research and development of microbially synthesized nanocellulose (BC/BNC) materials. Its independently developed modified materials have been widely applied in various fields, including new energy, fibers, leather, regenerative medicine materials, new functional ingredients for cosmetics, and novel food additives.
The company’s revenue is generated by providing high-performance, cost-effective, and easily scalable bio-based new materials.

## Funding rounds

- Series A, Dec 10, 2025 — Dalton Venture, Winzac Capital Management
- Angel, Oct 17, 2024 — MiraclePlus

## Investors

- MiraclePlus (https://capitalatlas.ai/funds/miracleplus) — Angel
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A
- Winzac Capital Management (https://capitalatlas.ai/funds/winzac-capital-management) — Series A